SS
Highly rated in
15
conditions
Highly rated in
15
conditions
Check Dr. Stephen D. Silberstein's experience treating your condition:
About Dr. Stephen D. Silberstein

Stephen Silberstein is a Neurologist in Philadelphia, Pennsylvania. Silberstein has been practicing medicine for over 59 years and is highly rated in 15 conditions, according to our data. His top areas of expertise are Migraine, Headache, Cluster Headache, and Migraine with Brainstem Aura. He is licensed to treat patients in Pennsylvania. Silberstein is currently accepting new patients.

His clinical research consists of co-authoring 250 peer reviewed articles and participating in 19 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Stephen D. Silberstein it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Stephen D. Silberstein accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
900 Walnut St, Suite 200, Philadelphia, PA 19107
Background & Education
Graduate Institution
Perelman School Of Med At The University Of Pennsylvania, 1963
Specialties
Neurology
Licenses
Psychiatry & Neurology in PA
Hospital Affiliations
Thomas Jefferson University Hospital
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


19 Clinical Trials

NINDS Clinical Research Collaboration Chronic Migraine Treatment Trial
Comparison Of Greater Occipital Nerve Block With Lidocaine And Bupivicaine Alone Or With Steroids In a Chronic Headache Population
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches
A Randomized, Double-Blind, Placebo-Controlled, Add-on Therapy Study of Xeomin (Incobotulinumtoxina) Versus Placebo in the Treatment of Trigeminal Neuralgia
A Single-Site, Double-Blind, Placebo-Controlled Cross-Over Trial Examining the Safety and Efficacy of Olanzapine Taken Daily for the Prevention of Episodic Migraine.
A Pilot Trial Examining the Safety and Efficacy of Frovatriptan as a Preemptive Treatment for Fasting-Induced Migraine Headache
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Cluster Headache
An Open-Label, Pilot Study Examining the Use of Soy Isoflavones in the Prevention of Menstrually-Associated Migraine
A 12-month Prospective, Randomized, Interventional, Global, Multi-center, Activecontrolled Study Comparing Sustained Benefit of Two Treatment Paradigms (Erenumab qm vs. Oral Prophylactics) in Adult Episodic Migraine Patients
An Open-label Pilot Study to Collect/Evaluate Data on the Use of Consecutive Daily Intravenous Doses of Depacon in Combination With Daily Dose of Depakote ER During a Cluster Headache Cycle.
A Study to Evaluate the Efficacy and Tolerability of STOPAIN in the Treatment of a Single Migraine Attack
View 18 Less Clinical Trials -

250 Total Publications

Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors